ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,631
Screening encounters
2,928
Diagnostic referrals
572
Outstanding pathways
226

Screening pathway

  1. Screening2,928Encounters
  2. Positive finding1,003Documented findings
  3. Referral572Diagnostic referrals
  4. Follow-up649Diagnostic visits
  5. Outcome346Resolved pathways

Stage totals use different units. Pending pathways: 226. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0779 · EXP-0779Synthetic · Site E

Full participant history through 2026-04-16, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-07-30
  4. · Diagnostic referral · EXP-0779-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Barrier documented · Transport difficulty
  9. · Diagnostic visit · Attended
  10. · Diagnosis · Colposcopy · Biopsy collected
  11. · Diagnosis · Histopathology · No high-grade lesion identified
  12. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-03-29
  13. · Follow-up disposition · Resolved · EXP-0779-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2631 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0844 · Expanded synthetic participant 0844Site C — Rural Outreach Programme
EXP-0846 · Expanded synthetic participant 0846Site D — Community Engagement Programme
EXP-0847 · Expanded synthetic participant 0847Site C — Rural Outreach Programme
EXP-0849 · Expanded synthetic participant 0849Site D — Community Engagement Programme
EXP-0852 · Expanded synthetic participant 0852Site A — Urban Referral Hub
EXP-0855 · Expanded synthetic participant 0855Site D — Community Engagement Programme
EXP-0856 · Expanded synthetic participant 0856Site E — Resource-Constrained Navigation Programme
EXP-0859 · Expanded synthetic participant 0859Site B — Peri-Urban Access Programme
EXP-0861 · Expanded synthetic participant 0861Site A — Urban Referral Hub
EXP-0865 · Expanded synthetic participant 0865Site C — Rural Outreach Programme
EXP-0866 · Expanded synthetic participant 0866Site C — Rural Outreach Programme
EXP-0867 · Expanded synthetic participant 0867Site B — Peri-Urban Access Programme
EXP-0869 · Expanded synthetic participant 0869Site B — Peri-Urban Access Programme
EXP-0871 · Expanded synthetic participant 0871Site B — Peri-Urban Access Programme
EXP-0872 · Expanded synthetic participant 0872Site E — Resource-Constrained Navigation Programme
EXP-0874 · Expanded synthetic participant 0874Site E — Resource-Constrained Navigation Programme
EXP-0875 · Expanded synthetic participant 0875Site C — Rural Outreach Programme
EXP-0876 · Expanded synthetic participant 0876Site B — Peri-Urban Access Programme
EXP-0878 · Expanded synthetic participant 0878Site C — Rural Outreach Programme
EXP-0881 · Expanded synthetic participant 0881Site B — Peri-Urban Access Programme
EXP-0883 · Expanded synthetic participant 0883Site C — Rural Outreach Programme
EXP-0884 · Expanded synthetic participant 0884Site D — Community Engagement Programme
EXP-0886 · Expanded synthetic participant 0886Site A — Urban Referral Hub
EXP-0891 · Expanded synthetic participant 0891Site D — Community Engagement Programme
EXP-0893 · Expanded synthetic participant 0893Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1203
HPV DNA
1289
Cytology
436

Navigation activity

Barrier documented
481
Contact attempt
836
Navigation intervention
207
Diagnostic booking
705
Diagnostic visit
649

Documented barriers

Contact difficulty
156
Transport difficulty
149
Appointment coordination
176

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.